Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Minoxidil effectively treats female pattern hair loss.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Dogs could be good models for studying human hair growth and hair loss.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Immune cells affect hair growth and could lead to new hair loss treatments.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.